Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome

Leukemia. 2003 Jun;17(6):1200-2. doi: 10.1038/sj.leu.2402894.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Chromosome Aberrations
  • Female
  • Humans
  • Karyotyping
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics*
  • Remission Induction
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Thalidomide